Related Experiment Video
Updated: Jun 2, 2026

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Patch testing is a useful investigation in children with eczema.
Manar Moustafa1, Catherine R Holden, Preeti Athavale
1Department of Paediatric Dermatology, Sheffield Children's NHS Foundation Trust, Western Bank, Sheffield S10 2TH, UK.
Patch testing identified relevant allergens in 44% of children with eczema, including common triggers like medicaments and nickel. This diagnostic tool is effective for pediatric allergic contact dermatitis, even in young children.
Area of Science:
- Pediatric Dermatology
- Allergology
- Contact Dermatitis
Background:
- Allergic contact dermatitis (ACD) in children is increasingly recognized as a contributor to eczema.
- Patch testing is a valuable diagnostic tool for identifying ACD in pediatric populations.
- This study focuses on children with various eczema types, primarily atopic dermatitis.
Purpose of the Study:
- To analyze patch test results in children with eczema.
- To identify common allergens responsible for ACD in this age group.
- To assess the diagnostic utility of patch testing for pediatric eczema.
Main Methods:
- Retrospective analysis of patch test results from 110 children (ages 2-18).
- Data collected from a contact dermatitis clinic between April 2002 and December 2008.
- Evaluation of positive reactions by gender, age group, and clinical relevance.
Main Results:
- 44% of children (48/110) had at least one relevant positive allergic reaction.
- Common allergens included medicaments, plant allergens, house dust mite, nickel, Amerchol® L101, and 2-bromo-2-nitropropane-1,3-diol.
- A positive allergen finding did not correlate with improved clinical outcomes.
Conclusions:
- Patch testing successfully identifies relevant allergens in 44% of children with eczema.
- Key allergens identified are medicaments, plant allergens, house dust mite, nickel, Amerchol® L101, and 2-bromo-2-nitropropane-1,3-diol.
- Patch testing is feasible and beneficial for children as young as 2 years with appropriate preparation.
More Related Videos
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017